收费全文 | 256811篇 |
免费 | 13290篇 |
国内免费 | 256篇 |
耳鼻咽喉 | 4076篇 |
儿科学 | 9895篇 |
妇产科学 | 7201篇 |
基础医学 | 37676篇 |
口腔科学 | 7366篇 |
临床医学 | 19958篇 |
内科学 | 47451篇 |
皮肤病学 | 7463篇 |
神经病学 | 23333篇 |
特种医学 | 11184篇 |
外国民族医学 | 55篇 |
外科学 | 40274篇 |
综合类 | 2202篇 |
一般理论 | 71篇 |
预防医学 | 13774篇 |
眼科学 | 6365篇 |
药学 | 17933篇 |
中国医学 | 516篇 |
肿瘤学 | 13564篇 |
2021年 | 1775篇 |
2020年 | 1558篇 |
2019年 | 2055篇 |
2018年 | 3896篇 |
2017年 | 3371篇 |
2016年 | 4389篇 |
2015年 | 4121篇 |
2014年 | 4737篇 |
2013年 | 7884篇 |
2012年 | 10390篇 |
2011年 | 11226篇 |
2010年 | 6522篇 |
2009年 | 4972篇 |
2008年 | 11295篇 |
2007年 | 12005篇 |
2006年 | 11875篇 |
2005年 | 11851篇 |
2004年 | 11259篇 |
2003年 | 11239篇 |
2002年 | 11058篇 |
2001年 | 12046篇 |
2000年 | 13240篇 |
1999年 | 9523篇 |
1998年 | 3036篇 |
1997年 | 2702篇 |
1996年 | 2251篇 |
1995年 | 1965篇 |
1994年 | 1864篇 |
1993年 | 1802篇 |
1992年 | 4643篇 |
1991年 | 4388篇 |
1990年 | 4353篇 |
1989年 | 4145篇 |
1988年 | 3630篇 |
1987年 | 3633篇 |
1986年 | 3400篇 |
1985年 | 3422篇 |
1984年 | 2692篇 |
1983年 | 2196篇 |
1982年 | 1553篇 |
1981年 | 1480篇 |
1979年 | 2408篇 |
1978年 | 1852篇 |
1977年 | 1642篇 |
1976年 | 1368篇 |
1975年 | 1674篇 |
1974年 | 1679篇 |
1973年 | 1612篇 |
1972年 | 1410篇 |
1971年 | 1354篇 |
Methods: Day 3 to day 7 after admission to a stroke unit, 64 persons with stroke were assessed twice, using the SwePASS, by two physiotherapists. Inter-rater reliability was determined using percentage-agreement and the rank-invariant method: relative position, relative concentration, and relative rank variance.
Results: The raters showed a percentage agreement of ≥75% in the assessments using the SwePASS. For 9 of the 12 items, the percentage agreement was >80%. For 8 of the 12 items, there was a statistically significant change in position, revealed in relative position values between 0.08 and 0.15. Three items had statistically significant positive relative concentration values between ?0.11 and 0.10. Except for a statistically significant negligible relative variance value of 0.01 for the items 1 and 8, there was no relative variance.
Conclusions: The SwePASS shows an acceptable inter-rater reliability, albeit with potential for improvement. The reliability can be improved by a consensus how to interpret the scale between the raters prior to implementation in the clinic. 相似文献
Methods: A retrospective analysis was performed to identify patients with isolated PCL injuries that underwent reconstruction between 2001 and 2014. Patients with multi-ligamentous injury or another concomitant knee pathology were excluded. Medical records were reviewed for demographic, clinical and operative data. Patients were contacted for administration of a telephone-based questionnaire which included the International Knee Documentation Committee (IKDC) Subjective Knee Evaluation form, Lysholm-Tegner scales, Marx activity scale (MAS), return to sport status, and patient satisfaction instruments.
Results: A total of 15 isolated PCL reconstructions in 14 patients with a mean age of 27.5 years (range 17–43) met the study inclusion criteria; mean follow up was 6.3 years (range 1.4–15.2). Pre-operatively, the primary complaint was knee instability in all patients; on physical examination, lack of a firm end point during posterior drawer testing was found in 93% (14/15) of the knees. In total, 12 of 15 knees underwent transtibial, single-bundle PCLR and three of 15 underwent tibial inlay, double bundle PCLR. Graft types included: quadriceps autograft (7/15), Achilles allograft (6/15), and hamstring autograft (2/15). There were no graft failures in our patient cohort. At most recent follow up the mean scores respectively on the IKDC form, Lysholm-Tegner scales and MAS were (standard deviation): 77.3 (16.5), 83.1 (17.9), 6.13 (2.6), and 7.1 (6.0). All fourteen patients were athletes prior to their injury and 79% (11/14) returned to sport and overall patient satisfaction was 9.2/10.
Conclusions: Isolated PCLR provides good outcomes at mean medium-term follow up with restoration of function, high rate of return to sport and overall patient satisfaction. 相似文献
Areas covered: This review focuses on current treatments and the future outlook for allergic rhinitis. Pharmacotherapy includes mast cell stabilizers, antihistamines, glucocorticosteroids (GCSs), leukotriene receptor antagonists, and nasal decongestants. Nasal GCSs are currently regarded as the most effective treatment and are considered first-line therapy together with non-sedating antihistamines. The new formulation MP29-02 combines the nasal GCS fluticasone propionate with azelastine in one single spray and has achieved greater improvements than those under monotherapy with modern GCSs or antihistamines. Furthermore, this review discusses allergen immunotherapy alone and in combination with modern monoclonal antibodies.
Expert opinion: Despite the variety of medications for allergic rhinitis, ranging from general symptomatic agents like GCSs or decongestants, to more specific ones like histamine receptor or leukotriene blockers, to causal therapy like immunotherapy, many patients still experience treatment failures or unsatisfactory results. The ultimate goal may be to endotype every downstream pathway separately in order to offer patients individualized, targeted therapy with specific antibodies against the respective pathway. 相似文献